Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: A very low dose naltrexone and buprenorphine open label trial

Publication Authors

Mannelli, Paolo,Wu, Li-Tzy,Peindl, Kathleen S.,Swartz, Marvin S.,Woody, George E.

Publisher Information

Type: 
Academic Journal
Year: 
2014
Date Note: 
1-May-14
Publisher: 
Drug and Alcohol Dependence